Cardiovascular Actions of KR-30006 and KR-1008, a New Dihydropyridine derivatives

새로운 Dihydropyridine 유도체, KR-30006과 KR-1008의 심장순환계 약리작용

  • Lee, Byung-Ho (Pharmaceutical Screening Center Korea Research Institute of Chemical Technology (KRICT)) ;
  • Jung, Yee-Sook (Pharmaceutical Screening Center Korea Research Institute of Chemical Technology (KRICT)) ;
  • Kwon, Kwang-Il (Pharmaceutical Screening Center Korea Research Institute of Chemical Technology (KRICT)) ;
  • Zee, Ok-Pyo (Pharmaceutical Screening Center Korea Research Institute of Chemical Technology (KRICT))
  • 이병호 (한국화학연구소 의약활성연구실) ;
  • 정이숙 (한국화학연구소 의약활성연구실) ;
  • 권광일 (한국화학연구소 의약활성연구실) ;
  • 지옥표 (한국화학연구소 의약활성연구실)
  • Published : 1989.06.28

Abstract

KR-1008 and KR-30006 are 1,4-dihydropyridine derivatives, new vasodilatory calcium antagonists from KRICT. Calcium antagonistic properties of the compounds were studied in the isolated heart (Langendorff preparation), pulmonary artery (vasodilation), and in the papillary muscle (negative inotropic effect) of the guinea pig. Antihypertensive effect were also investigated after i.v. or oral administration in the SHR (spontaneously hypertensive rat). They produced a sigificant inhibition of Ca-induced contraction in the guinea pig pulmonary artery at the concentrations of above $10^{-8}M$. The negative inotropic effect of the electrically stimulated papillary muscle appeared from the concentration of $10^{-6}M$, which is about hundred times higer than the concentration of vasodilation effect. Left ventricular pressure also decreased from the concentration of $3\;{\times}\;10^{-6}M$ in KR-1008 and KR-3006 in the Langendorff heart preparations. Coronary flow rate increased from $10^{-6}M$ in KR-1008 and nicardipine and appeared no change in KR-30006. The antihypertensive effect of KR-1008 (EC 20: $2.9\;{\mu}g/kg$) was potent more than nicardipine (EC 20: $3.4\;{\mu}g/kg$) and than Kr-30006 (EC 20: $6.8\;{\mu}g/kg$) was, after i.v. bolus injection in the anesthetized SHR. The antihypertensive effect in the conscious SHR appeared 30 minutes after oral administration of 10 mg/kg and persisted 4 hrs in KR-1008 and 12 hrs in KR-30006. Heart rate tended to increase for 0.5-1 hr after oral administration of the test compounds.

Keywords